Journal of Internal Medicine · 1989 · 10 citations · 9 references
Life SciencesBiochemistryImmunologyCellular ImmunologyImmunopathologyImmunoregulationEffector T Cell FunctionLymphocyte ActivationCappingLymphocyte Function TestingLymphocyte PhysiologyLymphocyte Proliferation Inhibition
Abstract Berntorp K, Ekman M, Berntorp E (Department of Internal Medicine. University of Lund, Malmö General Hospital, Malmö, Sweden). Cigarette smoke impairment of human lymphocyte function by inhibition of transglutaminase. The in‐vitro and in‐vivo effects of cigarette smoke were studied in human peripheral blood lymphocytes by applying a method for the capping of β 2 ‐microglobulin‐ or phytohaemagglutinin (PHA)‐stimulated lymphocyte transformation (measured as ( 3 H)thymidine incorporation) involving the transglutaminase pseudosubstrate monodansylthiacadaverine (MDTC), whose presence resulted in significantly reduced capping and ( 3 H)thymidine incorporation in a concentration‐dependent manner. The addition of dimethyl sulphoxide‐soluble particles from cigarette smoke to lymphocytes in vitro significantly reduced the capping ability and the PHA‐induced ( 3 H)thymidine incorporation. Whereas no significant change in MDTC‐dependent capping inhibition was seen in lymphocytes from smokers after 10 d abstinence from smoking, there was a marked decrease in ( 3 H)thymidine incorporation in lymphocytes from smokers after smoking three cigarettes following 10 h abstinence. The tentative conclusion is that exposure to cigarette smoke, or smoke extract, impairs MDTC‐dependent capping inhibition and PHA‐stimulated lymphocyte transformation by transglutaminase inhibition.
9
Isolation of Lymphocytes, Granulocytes and Macrophages
Arne Bøyum · Scandinavian Journal of Immunology · 1976 · 1.6K citations
Cigarette Smoke Contains Anticoagulants Against Fibrin Aggregation and Factor XIIIa in Plasma
Dennis K. Galanakis, P Laurent, Aaron Janoff et al. · Science · 1982 · 23 citations
Medicine, Biochemistry, Toxicology +14